Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3778269)

Published in Front Physiol on September 20, 2013

Authors

Benoît Jagu1, Flavien Charpentier, Gilles Toumaniantz

Author Affiliations

1: INSERM, UMR1087, l'institut du thorax, IRS-UN Nantes, France ; CNRS, UMR6291 Nantes, France ; Faculté de Médecine, Université de Nantes Nantes, France.

Articles cited by this

(truncated to the top 100)

MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68

Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol (2004) 11.39

A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci (1998) 9.06

The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem (2007) 8.94

Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene (2005) 5.58

Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science (1998) 4.58

Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A (2005) 4.14

A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res (2000) 3.68

Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol (2013) 3.33

New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation (2007) 2.89

Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A (2008) 2.79

Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation (2006) 2.72

Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol (2005) 2.60

Retracted The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem (2007) 2.60

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40

Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res (2002) 2.28

Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res (2004) 2.15

A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res (2003) 2.15

Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest (2013) 1.97

MOG1: a new susceptibility gene for Brugada syndrome. Circ Cardiovasc Genet (2011) 1.97

Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res (2007) 1.93

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92

Biology of cardiac sodium channel Nav1.5 expression. Cardiovasc Res (2011) 1.86

Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm (2011) 1.85

Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation (2006) 1.76

Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci U S A (1997) 1.76

The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet (1999) 1.75

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol (2010) 1.74

Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res (2004) 1.59

Alternative translation start sites and hidden coding potential of eukaryotic mRNAs. Bioessays (2008) 1.53

Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation. Heart Rhythm (2012) 1.51

Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome. Circulation (2007) 1.43

AGT genetic variation, plasma AGT, and blood pressure: An analysis of the Utah Genetic Reference Project pedigrees. Am J Hypertens (2010) 1.43

Genomics in sudden cardiac death. Circ Res (2004) 1.42

The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol (2012) 1.31

Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J (2003) 1.27

CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch (2009) 1.26

Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol (2011) 1.25

Molecular and genetic basis of sudden cardiac death. J Clin Invest (2013) 1.23

Activation of protein kinase A modulates trafficking of the human cardiac sodium channel in Xenopus oocytes. Circ Res (2000) 1.22

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovasc Res (2010) 1.21

Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation (2011) 1.20

Cardiac strong inward rectifier potassium channels. J Mol Cell Cardiol (2009) 1.19

Transmembrane biogenesis of Kv1.3. Biochemistry (2000) 1.14

Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron (1998) 1.14

The sialic acid component of the beta1 subunit modulates voltage-gated sodium channel function. J Biol Chem (2004) 1.12

S-Nitrosylation of cardiac ion channels. J Cardiovasc Pharmacol (2009) 1.12

Glycosylation influences voltage-dependent gating of cardiac and skeletal muscle sodium channels. J Membr Biol (1999) 1.11

Tandem promoters and developmentally regulated 5'- and 3'-mRNA untranslated regions of the mouse Scn5a cardiac sodium channel. J Biol Chem (2004) 1.10

A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.09

Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol (2012) 1.08

The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? J Cardiovasc Electrophysiol (2008) 1.07

Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5. J Biol Chem (2008) 1.06

Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res (2009) 1.06

Bioinformatic analyses of mammalian 5'-UTR sequence properties of mRNAs predicts alternative translation initiation sites. BMC Bioinformatics (2008) 1.06

Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc Natl Acad Sci U S A (2009) 1.05

Phosphorylation and putative ER retention signals are required for protein kinase A-mediated potentiation of cardiac sodium current. Circ Res (2002) 1.05

A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias. Can J Cardiol (2011) 1.05

Recent developments in the management of patients at risk for sudden cardiac death. Postgrad Med (2011) 1.04

Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm (2007) 1.04

Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail (2002) 1.04

Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure. Circulation (2011) 1.04

Alternative splicing of Nav1.5: an electrophysiological comparison of 'neonatal' and 'adult' isoforms and critical involvement of a lysine residue. J Cell Physiol (2008) 1.03

Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur J Pharmacol (2009) 1.03

The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.02

Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol (2013) 1.02

A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circ Arrhythm Electrophysiol (2012) 1.02

MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res (2012) 1.01

Long QT syndrome: beyond the causal mutation. J Physiol (2013) 1.00

Structure and function of splice variants of the cardiac voltage-gated sodium channel Na(v)1.5. J Mol Cell Cardiol (2010) 1.00

Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias. Am J Physiol Heart Circ Physiol (2013) 1.00

O-glycosylation of the cardiac I(Ks) complex. J Physiol (2011) 0.99

Expression and function of KCNH2 (HERG) in the human jejunum. Am J Physiol Gastrointest Liver Physiol (2003) 0.99

Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur J Hum Genet (2007) 0.97

PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease. Thromb Res (2001) 0.96

SCN5A overlap syndromes: no end to disease complexity? Europace (2008) 0.96

Differential sialylation modulates voltage-gated Na+ channel gating throughout the developing myocardium. J Gen Physiol (2006) 0.96

Ion-channel mRNA-expression profiling: Insights into cardiac remodeling and arrhythmic substrates. J Mol Cell Cardiol (2009) 0.95

Sudden cardiac death and inherited channelopathy: the basic electrophysiology of the myocyte and myocardium in ion channel disease. Heart (2012) 0.95

Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter. Cardiovasc Res (2004) 0.93

Quantitative trait loci for electrocardiographic parameters and arrhythmia in the mouse. J Mol Cell Cardiol (2010) 0.92

Protein kinase A and regulation of neonatal Nav1.5 expression in human breast cancer cells: activity-dependent positive feedback and cellular migration. Int J Biochem Cell Biol (2009) 0.91

Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J (2010) 0.91

The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis (1998) 0.89

Regulation of sodium currents through oxidation and reduction of thiol residues. Neuroscience (2000) 0.88

A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia. J Mol Cell Cardiol (2011) 0.88

Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias. J Electrocardiol (2007) 0.88

Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets. Cardiovasc Hematol Agents Med Chem (2009) 0.87

Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome. Heart Rhythm (2011) 0.87

Experimental Mapping of the Canine KCNJ2 and KCNJ12 Gene Structures and Functional Analysis of the Canine K(IR)2.2 ion Channel. Front Physiol (2012) 0.87

MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome. Circ Arrhythm Electrophysiol (2013) 0.86

Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome. Circ Arrhythm Electrophysiol (2013) 0.86

A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes. Hypertension (2005) 0.86

Mouse Models of SCN5A-Related Cardiac Arrhythmias. Front Physiol (2012) 0.85

New technologies in the genetic approach to sudden cardiac death in the young. Forensic Sci Int (2010) 0.83

Long QT syndrome-associated I593R mutation in HERG potassium channel activates ER stress pathways. Cell Biochem Biophys (2005) 0.83

Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients. Neurology (1996) 0.83

Sudden cardiac death in young athletes and nonathletes. Curr Opin Crit Care (2011) 0.83

Early LQT2 nonsense mutation generates N-terminally truncated hERG channels with altered gating properties by the reinitiation of translation. J Mol Cell Cardiol (2012) 0.82

The genetics of sudden cardiac death. Annu Rev Genomics Hum Genet (2012) 0.81

Articles by these authors

The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med (2010) 1.84

Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res (2005) 1.75

Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation (2005) 1.74

Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation (2005) 1.69

Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation (2005) 1.67

Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res (2006) 1.62

beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Cardiovasc Res (2003) 1.55

Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice. Cardiovasc Res (2011) 1.44

Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a. J Physiol (2005) 1.27

Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model. PLoS One (2010) 1.26

Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation (2005) 1.15

Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology. Circ Res (2003) 1.11

KCNQ1 channels voltage dependence through a voltage-dependent binding of the S4-S5 linker to the pore domain. J Biol Chem (2010) 1.10

Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice. J Clin Invest (2011) 1.09

Remodeling of excitation-contraction coupling in transgenic mice expressing ATP-insensitive sarcolemmal KATP channels. Am J Physiol Heart Circ Physiol (2003) 1.08

Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation (2008) 1.04

Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. J Am Coll Cardiol (2012) 1.01

Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction. Heart Rhythm (2009) 0.98

Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail (2010) 0.98

Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats. Br J Pharmacol (2004) 0.98

Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle. Physiol Genomics (2005) 0.96

KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines. J Physiol (2010) 0.95

Long-term amiodarone administration remodels expression of ion channel transcripts in the mouse heart. Circulation (2004) 0.93

Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway. Br J Pharmacol (2002) 0.93

Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias. J Cell Mol Med (2009) 0.90

RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration. Mol Cell Biol (2010) 0.90

Functional genomics of cardiac ion channel genes. Cardiovasc Res (2005) 0.87

Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity. Cardiovasc Res (2005) 0.87

Mass spectrometry-based identification of native cardiac Nav1.5 channel α subunit phosphorylation sites. J Proteome Res (2012) 0.85

Mouse Models of SCN5A-Related Cardiac Arrhythmias. Front Physiol (2012) 0.85

NHE-RF1 protein rescues DeltaF508-CFTR function. Am J Physiol Lung Cell Mol Physiol (2007) 0.84

Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block. Mol Ther (2008) 0.84

Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel. Biophys J (2010) 0.84

Transfer of rolf S3-S4 linker to HERG eliminates activation gating but spares inactivation. Biophys J (2009) 0.83

Characterization of beta3-adrenoceptors in human internal mammary artery and putative involvement in coronary artery bypass management. J Am Coll Cardiol (2005) 0.83

Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors. Exp Physiol (2009) 0.81

RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertension. Am J Physiol Cell Physiol (2012) 0.80

Cardiac FKBP12.6 overexpression protects against triggered ventricular tachycardia in pressure overloaded mouse hearts. Basic Res Cardiol (2012) 0.79

Transfected beta3- but not beta2-adrenergic receptors regulate cystic fibrosis transmembrane conductance regulator activity via a new pathway involving the mitogen-activated protein kinases extracellular signal-regulated kinases. Mol Pharmacol (2004) 0.79

Early ion-channel remodeling and arrhythmias precede hypertrophy in a mouse model of complete atrioventricular block. J Mol Cell Cardiol (2011) 0.79

T-type calcium current contributes to escape automaticity and governs the occurrence of lethal arrhythmias after atrioventricular block in mice. Circ Arrhythm Electrophysiol (2013) 0.78

Understanding the cardiac role of K2P channels: a new TASK for electrophysiologists. Cardiovasc Res (2007) 0.75

Familial Catecholamine-Induced QT Prolongation in Unexplained Sudden Cardiac Death. J Am Coll Cardiol (2017) 0.75

Cardiac arrhythmias are a major clinical problem. Guest editors' introduction. J Mol Cell Cardiol (2010) 0.75